Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 4:21 PM View:  | Cara Therapeutics, Inc. (CARA) | 05-Apr-24 | Sale (Planned) | 2,753 | $0.83 | $2,284.99 | (3%) 91.0K to 88.25K | |
| 04-Mar-24 4:24 PM View: | Cara Therapeutics, Inc. (CARA) | 29-Feb-24 | Sale (Planned) | 3,293 | $0.89 | $2,930.77 | (3%) 94.29K to 91.0K | |
| 05-Feb-24 4:34 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Feb-24 | Grant | 13,500 | -- | -- | 15% 88.56K to 102.06K | |
| 27-Jun-23 4:09 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Jun-23 | Sale (Planned) | 2,483 | $3.51 | $8,715.33 | (3%) 91.05K to 88.56K | |
| 06-Apr-23 5:14 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Apr-23 | Sale (Planned) | 2,481 | $4.91 | $12,181.70 | (3%) 93.53K to 91.05K | |
| 07-Mar-23 4:44 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-23 | Sale (Planned) | 6,256 | $9.71 | $60,745.80 | (6%) 99.78K to 93.53K | |
| 12-Feb-24 5:16 PM View: | Cara Therapeutics, Inc. (CARA) | 08-Feb-23 | Sale (Planned) | 7,770 | $0.53 | $4,118.10 | (8%) 102.06K to 94.29K | |
| 23-Dec-22 4:52 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Dec-22 | Market Sale (Planned) | 2,561 | $11.27 | $28,862.50 | (3%) 102.34K to 99.78K | (8%) |
| 05-Apr-22 5:51 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Apr-22 | Market Sale (Planned) | 1,642 | $11.91 | $19,556.20 | (2%) 103.99K to 102.34K | (2%) |
| 04-Mar-22 5:51 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-22 | Market Sale (Planned) | 1,787 | $11.38 | $20,336.10 | (2%) 105.77K to 103.99K | (7%) |
| 01-Mar-22 4:19 PM View: | Cara Therapeutics, Inc. (CARA) | 28-Feb-22 | Grant | 5,333 | -- | -- | 5% 100.44K to 105.77K | |
| 01-Mar-22 4:19 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Grant | 20,000 | -- | -- | 24% 82.41K to 102.41K | |
| 01-Mar-22 4:19 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Sale (Planned) | 1,972 | $10.29 | $20,291.90 | (2%) 102.41K to 100.44K | |
| 21-Dec-21 5:28 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Dec-21 | Grant | 11,495 | -- | -- | 16% 70.92K to 82.41K | |
| 01-Sep-21 6:09 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Aug-21 | Market Sale (Planned) | 1,759 | $14.20 | $24,977.80 | (2%) 72.68K to 70.92K | (11%) |
| 26-Aug-21 6:17 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Aug-21 | Grant | 5,334 | -- | -- | 8% 67.34K to 72.68K | |
| 01-Apr-21 7:51 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Mar-21 | Grant | 16,000 | -- | -- | 31% 51.34K to 67.34K | |
| 08-Mar-21 5:47 PM View: | Cara Therapeutics, Inc. (CARA) | 05-Mar-21 | Market Sale (Planned) | 3,090 | $17.98 | $55,558.20 | (6%) 54.43K to 51.34K | |
| 08-Mar-21 5:47 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Mar-21 | Grant | 10,000 | -- | -- | 23% 44.43K to 54.43K | |
| 25-Feb-21 9:06 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-21 | Market Sale (Planned) | 4,004 | $19.33 | $77,397.30 | (8%) 48.44K to 44.43K | |
| 25-Feb-21 9:06 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Feb-21 | Grant | 6,000 | -- | -- | 14% 42.44K to 48.44K | |
| 30-Dec-20 6:16 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Dec-20 | Market Sale (Planned) | 1,946 | $15.30 | $29,773.80 | (4%) 44.38K to 42.44K | (< 1%) |
| 29-Dec-20 6:42 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Dec-20 | Grant | 6,000 | -- | -- | 16% 38.38K to 44.38K | |
| 21-Apr-20 6:50 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Apr-20 | Market Sale (Planned) | 2,721 | $15.56 | $42,338.80 | (7%) 41.1K to 38.38K | (1%) |
| 21-Apr-20 6:50 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Apr-20 | Grant | 8,334 | -- | -- | 25% 32.77K to 41.1K | |
| 26-Feb-20 5:10 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Feb-20 | Grant | 16,000 | -- | -- | 95% 16.77K to 32.77K | |
| 04-Dec-19 7:52 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Dec-19 | Market Sale (Planned) | 3,980 | $17.05 | $67,859.00 | (19%) 20.75K to 16.77K | 8% |
| 04-Dec-19 7:52 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Dec-19 | Grant | 8,333 | -- | -- | 67% 12.42K to 20.75K | |
| 30-May-19 6:19 PM View: | Cara Therapeutics, Inc. (CARA) | 29-May-19 | Market Sale (Planned) | 2,303 | $21.38 | $49,238.10 | (16%) 14.72K to 12.42K | 27% |
| 30-May-19 6:19 PM View: | Cara Therapeutics, Inc. (CARA) | 28-May-19 | Grant | 8,333 | -- | -- | 130% 6.39K to 14.72K | |
| 02-Jan-19 5:56 PM View: | Cara Therapeutics, Inc. (CARA) | 28-Dec-18 | Market Sale (Planned) | 3,100 | $12.51 | $38,781.00 | (33%) 9.49K to 6.39K | (26%) |
| 31-Dec-18 4:19 PM View: | Cara Therapeutics, Inc. (CARA) | 27-Dec-18 | Grant | 9,486 | -- | -- | 100% 0 to 9.49K |